Displaying posts categorized under

Autoimmune Disease

Ulcerative Colitis saturated with alternative herbal treatment known as inForce Immune Builder.

Personal Update:

As most of you now know from my testimony above, I quit smoking for the LAST time on June 1st 2010 and I used the inLife electronic cigarette to do so. I have to say right here, quitting with the e-cig was the easiest part. My big problems would start, (as I feared they would) a few weeks later. For more details about those problems, please see the video of my testimony above.) …

A Life long battle with arthritis, fibro, auto-immune disease, and scoliosis. A brighter future with inForce™ Immune Builder with PSK

I was born with Scoliosis, Pediatric Fibromyalgia and a weakened auto-immune system. What that means is from infancy, until the age of 11 years old, I woke up in the morning to start my day, unable to open my eyes.

They were glued shut from an excess accumulation of mucus overnight, which would harden and interlock my eye-lashes thus, by dawn my eyes were sealed shut. My mother’s daily routine was to place hot, wet towels over my eyes to loosen the mucus and remove it without removing my eye-lashes as well. Once that was done and I could open my eyes to see, my mother would drive me to my doctors office, where I would have to sit at a machine, equivalent to a vacuum cleaner sucking excess mucus from each nostril. It was a painful, childhood experience which I will never forget….

Using alternative herbal medicine instead of Chemotherapy.

I had to go through chemotherapy in my early 30?s for breast cancer – if I had it to do over again I would only take the InForce and nothing else – in fact, if (God Forbid) I ever have the cancer again I will refuse taking horrible chemo and only take the InForce!! I totally believe in the InLife InForce Products and know that I am going to help people be saved from many auto-immune deficiency diseases!!…

Alternative Herbal Treatment Ulcerative Colitis using inLife inForce Immune Builder

Dr. Mark Flannery Joins inLife LLC’s Board as Medical Advisor

inLife, LLC today announced Dr. Mark Flannery joins inLife’s Board as Medical Advisor. Dr. Flannery joins inLife to bring awareness and enlightenment to the public of inLife’s new immunological nutritional supplement, inForce Immune Builder.[…]

Antitumor effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model

Cryoablation is a low-invasive surgical treatment for malignant tumors. It may induce an immunological response leading to the eradication of distant metastases or alternatively it might promote the growth of residual tumors. In this paper we confirm the occurrence of both phenomena and we describe the preventive effect of a protein-bound polysaccharide preparation. Metastatic liver tumors were produced […]

Alternating immunotherapy of advanced gastric carcinoma: A randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection

A total of 103 patients with advanced gastric carcinoma were randomized after curative surgery to receive an alternate administration of carabzilquinone (CQ) and PSK (Krestin) or carbazilquinone alone. Each course of therapies started 1 week after the surgical operation and therapy schedules consisted of 9 courses. In each course of 6 weeks, CQ was administered on day 0, 8, and 15. In combined immunochemotherapy group, PSK was given orally in 3-divided doses of 2g/m^2/day from the day of the third CQ administration for consecutive 4 weeks. Estimated survival rate and cumulative survival curve [….]

Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators.

The in vitro and in vivo research demonstrates that the reviewed botanical medicines modulate the secretion of multiple cytokines. The reported therapeutic success of these plants by traditional cultures and modern clinicians may be partially due to their effects on cytokines. Phytotherapy offers a potential therapeutic modality for the treatment of many differing conditions involving cytokines. Given the activity demonstrated by many of the reviewed herbal medicines and the increasing awareness of the broad-spectrum effects of cytokines on autoimmune conditions and chronic degenerative processes, further study of phytotherapy for cytokine-related diseases and syndromes is warranted.[…]

Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I’m-Yunity (PSP).

Aqueous extracts of I’m-Yunity (PSP) induces cell cycle arrest and alterations in the expression of apoptogenic/anti-apoptotic and extracellular signaling regulatory proteins in human leukemia cells, the net result being suppression of proliferation and increase in apoptosis. These findings may contribute to the reported clinical and overall health effects of I’m-Yunity (PSP).[…]

Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30.

In search of natural bioactive microbial compounds with adjuvant properties, we have previously showed that the polysaccharopeptide (PSP), isolated from Chinese medicinal mushroom Coriolus versicolor, was able to enhance the cytotoxicity of certain S-phase targeted-drugs on human leukemic HL-60 cells via some cell-cycle and apoptotic-dependent pathways. The present study aimed to investigate whether the synergism of mechanisms of PSP with certain chemotherapeutic drugs also applies to human breast cancer. PSP treatment enhanced the cytotoxicity of doxorubicin (Doxo), etoposide (VP-16) but not cytarabine (Ara-C). Bivariate bromodeoxyuridine (BrdUrd)/DNA flow cytometry analysis estimated a longer DNA synthesis time (Ts) for the PSP treated cancerous cells suggesting that PSP enhanced the apoptotic effect of Doxo and VP-16 via creating an S-phase trap in the human breast cancer cell line ZR-75-30. The participation of PSP in the apoptotic machinery of the chemotherapeutic agents was further supported by a reduced ratio of protein expression of Bcl-xL/Bax of the cancer cells. This study provides further insight into the synergistic mechanisms of PSP and supports the hypothesis that the anticancer potentials of PSP is not limited to leukemia but may also be used as an adjuvant therapy for breast cancers.[…]